Inventor · disambiguated record
Klaus Strein
Also filed as: STREIN KLAUS
35 granted patents·14 pending applications·614 citations·filing 1982–2022
98Inventor score
Files withBOEHRINGER MANNHEIM GMBH22ENGMAB SARL10ENGMAB AG7BOEHRINGER MANNHEIM PHARM CORP4LAMKAP BIO BETA LTD2
Top patents by PatentIndex Score
49 records- 0194US10683369B2Monoclonal antibodies against BCMAENGMAB SARL·Filed 2016·Granted Jun 16, 2020·14 cites·21 claims
- 0292US9963513B2Method for the selection of antibodies against BCMAENGMAB AG·Filed 2014·Granted May 8, 2018·19 cites·5 claims
- 0391US4826847ABeta-blocking oxindole derivativesBOEHRINGER MANNHEIM GMBH·Filed 1986·Granted May 2, 1989·66 cites·13 claims
- 0489US5760069AMethod of treatment for decreasing mortality resulting from congestive heart failureBOEHRINGER MANNHEIM PHARM CORP·Filed 1995·Granted Jun 2, 1998·71 cites·7 claims
- 0588US5902821AUse of carbazole compounds for the treatment of congestive heart failureBOEHRINGER MANNHEIM PHARM CORP·Filed 1996·Granted May 11, 1999·65 cites·11 claims
- 0687US10253104B2Bispecific antibodies against CD3ϵ and BCMAENGMAB AG·Filed 2015·Granted Apr 9, 2019·10 cites·16 claims
- 0784US10077315B2Bispecific antibodies against CD3 and BCMAENGMAB AG·Filed 2014·Granted Sep 18, 2018·6 cites·5 claims
- 0883US5366965ARegimen for treatment or prophylaxis of osteoporosisBOEHRINGER MANNHEIM GMBH·Filed 1993·Granted Nov 22, 1994·71 cites·12 claims
- 0983US4954498ATricyclic benzimidazole compounds, pharmaceutical compositions and methods of useBOEHRINGER MANNHEIM GMBH·Filed 1988·Granted Sep 4, 1990·29 cites·8 claims
- 1083US4835280AIndoline compounds for synthesis of pharmaceutically active pyrrolobenzimidazolesBOEHRINGER MANNHEIM GMBH·Filed 1987·Granted May 30, 1989·26 cites·13 claims
- 1182US11124577B2Bispecific antibody against BCMA and CD3 and an immunological drug for combined use in treating multiple myelomaENGMAB SARL·Filed 2017·Granted Sep 21, 2021·5 cites·8 claims
- 1280US10851171B2Method for the selection of antibodies against BCMAENGMAB SARL·Filed 2018·Granted Dec 1, 2020·1 cites·4 claims
- 1380US4863945APyrrolobenzimidazoles and pharmaceutical compositions containing themBOEHRINGER MANNHEIM GMBH·Filed 1987·Granted Sep 5, 1989·30 cites·20 claims
- 1478US4874756ABenzodipyrroles, processes for the preparation thereof and pharmaceutical compositions containing themBOEHRINGER MANNHEIM GMBH·Filed 1986·Granted Oct 17, 1989·27 cites·16 claims
- 1576US4985448AUreidoindoles, pharmaceutical compositions and methods for erythrocyte and thrombocyte aggregation inhibitionBOEHRINGER MANNHEIM GMBH·Filed 1989·Granted Jan 15, 1991·19 cites·15 claims
- 1675USRE40000EMethod of treatment for decreasing mortality resulting from congestive heart failureSB PHARMCO INC·Filed 2003·Granted Jan 8, 2008·4 cites·9 claims
- 1773US4666923APyrrolobenzimidazoles for treating heart or circulatory diseasesBOEHRINGER MANNHEIM GMBH·Filed 1985·Granted May 19, 1987·17 cites·12 claims
- 1873US2023322957A1Monoclonal antibodies against bcmaENGMAB SARL·Filed 2022·Application pending·0 cites
- 1970US4695567APyrrolobenzimidazoles, pharmaceutical compositions containing them and method of using them to treat certain heart and circulatory diseasesBOEHRINGER MANNHEIM GMBH·Filed 1986·Granted Sep 22, 1987·17 cites·18 claims
- 2069US4810801APyrrolobenzimidazoles, pharmaceutical compositions containing them, and use of them to treat certain heart and circulatory diseasesBOEHRINGER MANNHEIM GMBH·Filed 1987·Granted Mar 7, 1989·14 cites·18 claims
- 2168US5783558AParathormone fragments, their preparation and medicaments containing theseBOEHRINGER MANNHEIM GMBH·Filed 1993·Granted Jul 21, 1998·24 cites·10 claims
- 2268US5116843ATricyclic benzimidazole compounds, pharmaceutical compositions and methods of useBOEHRINGER MANNHEIM GMBH·Filed 1990·Granted May 26, 1992·20 cites·27 claims
- 2368US2021070873A1Method for the selection of antibodies against bcmaENGMAB SARL·Filed 2020·Application pending·0 cites
- 2466US4863949AAminopropanol derivatives, processes for the preparation thereof, the use thereof and pharmaceutical compositions containing themBOEHRINGER MANNHEIM GMBH·Filed 1987·Granted Sep 5, 1989·13 cites·15 claims
- 2564US2020385471A1Bispecific antibodies against cd3epsilon and bcma for use in treatment of diseasesENGMAB SARL·Filed 2020·Application pending·0 cites
- 2662US2020283545A1Monoclonal antibodies against bcmaENGMAB SARL·Filed 2020·Application pending·0 cites
- 2760US5373019APharmaceutical lactam compositions for inhibition of erythrocyte and thrombocyte aggregationBOEHRINGER MANNHEIM GMBH·Filed 1991·Granted Dec 13, 1994·13 cites·8 claims
- 2860US2003105138A1Method of treatment for decreasing mortality resulting from congestive heart failureBOEHRINGER MANNHEIM PHARM CORP·Filed 2002·Application pending·0 cites
- 2960US2022017631A1Bispecific antibody against bcma and cd3 and an immunological drug for combined use in treating multiple myelomaENGMAB SARL·Filed 2021·Application pending·0 cites
- 3060US2022002427A1Bispecific antibody against bcma and cd3 and an immunological drug for combined use in treating multiple myelomaENGMAB SARL·Filed 2021·Application pending·0 cites
- 3158US4612313APharmaceutical phenylacetonitrile derivativesBOEHRINGER MANNHEIM GMBH·Filed 1985·Granted Sep 16, 1986·9 cites·23 claims
- 3256US2020255521A1Bispecific antibodies against cd3epsilon and ror1ENGMAB SARL·Filed 2020·Application pending·0 cites
- 3356US2001044455A1Method of treatment for decreasing mortality resulting from congestive heat failureBOEHRINGER MANNHEIM PHARM CORP·Filed 2001·Application pending·0 cites
- 3454US4710510APyrrolobenzimidazoles, pharmaceutical compositions containing them, and use of them to treat certain heart and circulatory diseasesBOEHRINGER MANNHEIM GMBH·Filed 1985·Granted Dec 1, 1987·6 cites·14 claims
- 3552US2024084001A1Bispecific antibodies against ceacam5 and cd47LAMKAP BIO BETA LTD·Filed 2022·Application pending·0 cites
- 3650US2016297881A1BISPECIFIC ANTIBODIES AGAINST CD3EPSILON and ROR1ENGMAB AG·Filed 2014·Application pending·0 cites
- 3749US4831032ACardiotonic benzimidazolesBOEHRINGER MANNHEIM GMBH·Filed 1986·Granted May 16, 1989·5 cites·20 claims
- 3847US4721717Aα-(aminoalkylaminomethyl)phenylmethanols, composition containing them, and use thereof to treat certain heart and circulatory diseasesBOEHRINGER MANNHEIM GMBH·Filed 1985·Granted Jan 26, 1988·4 cites·15 claims
- 3946US11952421B2Bispecific antibodies against CD3EPSILON and ROR1BRISTOL MYERS SQUIBB CO·Filed 2015·Granted Apr 9, 2024·0 cites·6 claims
- 4046US4479962AIndazoloxypropanolamine derivatives and use in combating, and for the prophylaxis of, cardiac and circulatory diseasesBOEHRINGER MANNHEIM GMBH·Filed 1982·Granted Oct 30, 1984·3 cites·32 claims
- 4145US11555071B2Bispecific antibodies against CEACAM5 and CD47LAMKAP BIO BETA LTD·Filed 2019·Granted Jan 17, 2023·0 cites·23 claims
- 4242USRE40707EUse of carbazole compounds for the treatment of congestive heart failureSB PHARMCO INC·Filed 1996·Granted May 5, 2009·4 cites·16 claims
- 4342US2017327580A1Bispecific antibodies against cd3 epsilon and bcma for use in treatment of diseasesENGMAB AG·Filed 2015·Application pending·0 cites
- 4437US12441807B2Bispecific antibodies against CEACAM5 and CD3Lamkap Bio Alpha AG·Filed 2020·Granted Oct 14, 2025·0 cites·11 claims
- 4534US2017327579A1Bispecific antibodies against cd3epsilon and bcmaENGMAB AG·Filed 2015·Application pending·0 cites
- 4633US2017306044A1Bispecific antibodies against cd3epsilon and ror1 for use in the treatment of ovarian cancerENGMAB AG·Filed 2015·Application pending·0 cites
- 4732US4963686ACertain pyridinoylamino-indolin-2-one derivativesBOEHRINGER MANNHEIM GMBH·Filed 1988·Granted Oct 16, 1990·0 cites·13 claims
- 4831US4880805AUse of alkylenediamine derivatives for the treatment of blood flow disturbances and pharmaceutical compositions containing themBOEHRINGER MANNHEIM GMBH·Filed 1988·Granted Nov 14, 1989·1 cites·11 claims
- 4930US4780474AUse of alkylenediamine derivatives for the treatment of blood flow disturbances and pharmaceutical compositions containing themBOEHRINGER MANNHEIM GMBH·Filed 1987·Granted Oct 25, 1988·1 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →